المؤلفون: Biddlecom A; Independent researcher, New York, NY USA., Sully EA; Guttmacher Institute, New York, NY USA., Kantorová V; Population Division, Department of Economic and Social Affairs, United Nations, New York, NY USA., Wheldon MC; Population Division, Department of Economic and Social Affairs, United Nations, New York, NY USA., Lince-Deroche N; Independent researcher, Athens, Greece., Riley T; Department of Epidemiology, University of Washington, Seattle, WA USA.

المصدر: Population research and policy review [Popul Res Policy Rev] 2023; Vol. 42 (1), pp. 13. Date of Electronic Publication: 2023 Feb 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Kluwer Academic Publishing Country of Publication: Netherlands NLM ID: 8309372 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0167-5923 (Print) Linking ISSN: 01675923 NLM ISO Abbreviation: Popul Res Policy Rev Subsets: PubMed not MEDLINE

المؤلفون: Jones SP; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk., Firth JD; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk., Wheldon MC; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk., Atobe M; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk.; Asahi Kasei Pharma Corporation 632-1 Mifuku, Izunokuni Shizuoka 410-2321 Japan., Hubbard RE; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk.; Vernalis (R&D) Ltd. Granta Park, Abington Cambridge CB21 6GB UK., Blakemore DC; Medicine Design, Pfizer Inc. 445 Eastern Point Road Groton CT 06340 USA., De Fusco C; Bayer AG, Research and Development, Pharmaceuticals, Synthetic Modalities 13353 Berlin Germany., Lucas SCC; Hit Discovery, Discovery Sciences, R&D, AstraZeneca Cambridge CB4 0WG UK., Roughley SD; Vernalis (R&D) Ltd. Granta Park, Abington Cambridge CB21 6GB UK., Vidler LR; Amphista Therapeutics The Cori Building, Granta Park, Great Abington Cambridge CB21 6GQ UK., Whatton MA; Evotec (UK) Ltd Dorothy Crowfoot Hodgkin Campus, 114 Innovation Drive, Milton Park, Abingdon Oxon OX14 4RZ UK., Woolford AJ; Astex Pharmaceuticals 436 Cambridge Science Park, Milton Road Cambridge CB4 0QA UK., Wrigley GL; Medicinal Chemistry, Oncology R&D, AstraZeneca Cambridge UK., O'Brien P; Department of Chemistry, University of York Heslington York YO10 5DD UK peter.obrien@york.ac.uk.

المصدر: RSC medicinal chemistry [RSC Med Chem] 2022 Oct 11; Vol. 13 (12), pp. 1614-1620. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101759460 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8682 (Electronic) Linking ISSN: 26328682 NLM ISO Abbreviation: RSC Med Chem Subsets: PubMed not MEDLINE

المؤلفون: Kantorová V; Population Division, United Nations, Department of Economic and Social Affairs, New York, NY, United States of America., Wheldon MC; Population Division, United Nations, Department of Economic and Social Affairs, New York, NY, United States of America., Dasgupta ANZ; Population Division, United Nations, Department of Economic and Social Affairs, New York, NY, United States of America., Ueffing P; Population Division, United Nations, Department of Economic and Social Affairs, New York, NY, United States of America., Castanheira HC; United Nations, Economic Commission for Latin America and the Caribbean, Santiago de Chile, Chile.

المصدر: PloS one [PLoS One] 2021 Mar 04; Vol. 16 (3), pp. e0247479. Date of Electronic Publication: 2021 Mar 04 (Print Publication: 2021).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: Contraception* , Contraception Behavior* , Family Planning Services* , Health Services Accessibility*, Adolescent ; Adult ; Bayes Theorem ; Female ; Humans ; Young Adult

المؤلفون: Downes TD; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Jones SP; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Klein HF; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Wheldon MC; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Atobe M; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK.; Asahi Kasei Pharma Corporation, 632-1 Mifuku, Izunokuni, Shizuoka, 410-2321, Japan., Bond PS; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Firth JD; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Chan NS; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Waddelove L; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK., Hubbard RE; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK.; Vernalis (R&D) Ltd, Granta Park, Abington, Cambridge, CB21 6GB, UK., Blakemore DC; Medicine Design, Pfizer Inc, 445 Eastern Point Road, Groton, CT 06340, USA., De Fusco C; Discovery Sciences, R&D, AstraZeneca, Cambridge, CB4 0WG, UK., Roughley SD; Vernalis (R&D) Ltd, Granta Park, Abington, Cambridge, CB21 6GB, UK., Vidler LR; Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK., Whatton MA; Eli Lilly and Company Limited, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey, GU20 6PH, UK., Woolford AJ; Astex Pharmaceuticals, 436 Cambridge Science Park, Milton Road, Cambridge, CB4 0QA, UK., Wrigley GL; Medicinal Chemistry, Oncology R&D, AstraZeneca, CB4 0WG, Cambridge, UK., O'Brien P; Department of Chemistry, University of York, Heslington, York, YO10 5DD, UK.

المصدر: Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2020 Jul 22; Vol. 26 (41), pp. 8969-8975. Date of Electronic Publication: 2020 Jul 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 9513783 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-3765 (Electronic) Linking ISSN: 09476539 NLM ISO Abbreviation: Chemistry Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Kantorová V; Population Division, Department of Economic and Social Affairs, United Nations, New York, New York, United States of America., Wheldon MC; Population Division, Department of Economic and Social Affairs, United Nations, New York, New York, United States of America., Ueffing P; Population Division, Department of Economic and Social Affairs, United Nations, New York, New York, United States of America., Dasgupta ANZ; Population Division, Department of Economic and Social Affairs, United Nations, New York, New York, United States of America.

المصدر: PLoS medicine [PLoS Med] 2020 Feb 18; Vol. 17 (2), pp. e1003026. Date of Electronic Publication: 2020 Feb 18 (Print Publication: 2020).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE

مواضيع طبية MeSH: Health Services Accessibility* , Marital Status*, Contraception/*statistics & numerical data , Family Planning Services/*statistics & numerical data , Health Services Needs and Demand/*statistics & numerical data, Adolescent ; Adult ; Bayes Theorem ; Female ; Global Health ; Humans ; Middle Aged ; Models, Statistical ; Young Adult

المؤلفون: Large JM; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK. Electronic address: jonathan.large@lifearc.org., Birchall K; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Bouloc NS; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Merritt AT; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Smiljanic-Hurley E; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Tsagris DJ; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Wheldon MC; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Ansell KH; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Coombs PJ; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Kettleborough CA; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Whalley D; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Stewart LB; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Bowyer PW; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Baker DA; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Osborne SA; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK.

المصدر: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2019 Oct 01; Vol. 29 (19), pp. 126610. Date of Electronic Publication: 2019 Aug 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE

مواضيع طبية MeSH: Bridged Bicyclo Compounds, Heterocyclic/*pharmacology , Cyclic GMP-Dependent Protein Kinases/*antagonists & inhibitors , Imidazoles/*chemistry , Malaria/*drug therapy , Plasmodium falciparum/*drug effects , Protein Kinase Inhibitors/*pharmacology , Pyridines/*chemistry, Bridged Bicyclo Compounds, Heterocyclic/chemistry ; Humans ; Malaria/enzymology ; Malaria/parasitology ; Models, Molecular ; Molecular Docking Simulation ; Plasmodium falciparum/enzymology ; Protein Conformation ; Protein Kinase Inhibitors/chemistry

المؤلفون: Large JM; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK. Electronic address: jonathan.large@lifearc.org., Birchall K; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Bouloc NS; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Merritt AT; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Smiljanic-Hurley E; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Tsagris DJ; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Wheldon MC; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Ansell KH; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Coombs PJ; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Kettleborough CA; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Whalley D; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK., Stewart LB; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Bowyer PW; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Baker DA; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK., Osborne SA; Centre for Therapeutics Discovery, LifeArc, Accelerator Building, Open Innovation Campus, Stevenage SG1 2FX, UK.

المصدر: Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2019 Feb 01; Vol. 29 (3), pp. 509-514. Date of Electronic Publication: 2018 Nov 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9107377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-3405 (Electronic) Linking ISSN: 0960894X NLM ISO Abbreviation: Bioorg Med Chem Lett Subsets: MEDLINE

مواضيع طبية MeSH: Antimalarials/*pharmacology , Cyclic GMP-Dependent Protein Kinases/*antagonists & inhibitors , Imidazoles/*pharmacology , Plasmodium falciparum/*drug effects , Protein Kinase Inhibitors/*pharmacology , Pyridines/*pharmacology, Antimalarials/chemical synthesis ; Antimalarials/chemistry ; Cyclic GMP-Dependent Protein Kinases/metabolism ; Dose-Response Relationship, Drug ; Imidazoles/chemical synthesis ; Imidazoles/chemistry ; Ligands ; Molecular Structure ; Parasitic Sensitivity Tests ; Plasmodium falciparum/enzymology ; Protein Kinase Inhibitors/chemical synthesis ; Protein Kinase Inhibitors/chemistry ; Pyridines/chemical synthesis ; Pyridines/chemistry ; Structure-Activity Relationship

المؤلفون: Dissanayake AM; Counties Manukau Health Auckland New Zealand., Wheldon MC; Auckland University of Technology Auckland New Zealand.; Middlemore Clinical Trials Middlemore Hospital Auckland New Zealand., Hood CJ; Counties Manukau Health Auckland New Zealand.

المصدر: Pharmacology research & perspectives [Pharmacol Res Perspect] 2018 Sep 14; Vol. 6 (5), pp. e00424. Date of Electronic Publication: 2018 Sep 14 (Print Publication: 2018).

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 101626369 Publication Model: eCollection Cited Medium: Internet ISSN: 2052-1707 (Electronic) Linking ISSN: 20521707 NLM ISO Abbreviation: Pharmacol Res Perspect Subsets: MEDLINE

مواضيع طبية MeSH: Creatinine/*metabolism , Diabetes Mellitus, Type 2/*drug therapy , Hypoglycemic Agents/*pharmacokinetics , Metformin/*pharmacokinetics , Renal Insufficiency, Chronic/*physiopathology, Administration, Oral ; Adult ; Aged ; Creatinine/blood ; Creatinine/urine ; Diabetes Mellitus, Type 2/complications ; Female ; Glomerular Filtration Rate ; Humans ; Hypoglycemic Agents/therapeutic use ; Kidney/physiopathology ; Male ; Metformin/therapeutic use ; Middle Aged ; Models, Biological ; Renal Elimination ; Renal Insufficiency, Chronic/complications

المؤلفون: Baker DA; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. david.baker@lshtm.ac.uk., Stewart LB; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Large JM; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Bowyer PW; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Ansell KH; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Jiménez-Díaz MB; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., El Bakkouri M; Structural Genomics Consortium, University of Toronto, MaRS South Tower, 101 College Street, Toronto, ON, Canada, M5G 1L7.; Toronto General Hospital Research Institute, 610 University Avenue, Toronto, ON, Canada, M5G 2M9., Birchall K; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Dechering KJ; TropIQ Health Sciences, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands., Bouloc NS; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Coombs PJ; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Whalley D; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Harding DJ; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Smiljanic-Hurley E; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Wheldon MC; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Walker EM; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Dessens JT; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Lafuente MJ; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., Sanz LM; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., Gamo FJ; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., Ferrer SB; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., Hui R; Structural Genomics Consortium, University of Toronto, MaRS South Tower, 101 College Street, Toronto, ON, Canada, M5G 1L7.; Toronto General Hospital Research Institute, 610 University Avenue, Toronto, ON, Canada, M5G 2M9., Bousema T; Department of Medical Microbiology, Radboud University Medical Center, 6525 HP, Nijmegen, The Netherlands., Angulo-Barturén I; Tres Cantos Medicines Development Campus-Diseases of the Developing World, GlaxoSmithKline, Tres Cantos,, 28760, Madrid, Spain., Merritt AT; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Croft SL; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Gutteridge WE; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK., Kettleborough CA; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK., Osborne SA; LifeArc, Accelerator Building, Open Innovation Campus, Stevenage, SG1 2FX, UK.

المصدر: Nature communications [Nat Commun] 2017 Sep 05; Vol. 8 (1), pp. 430. Date of Electronic Publication: 2017 Sep 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Cyclic GMP-Dependent Protein Kinases/*antagonists & inhibitors , Imidazoles/*therapeutic use , Malaria/*enzymology , Malaria/*transmission , Pyridines/*therapeutic use, Animals ; Cell Line ; Crystallography, X-Ray ; Culicidae ; Cyclic GMP-Dependent Protein Kinases/chemistry ; Cyclic GMP-Dependent Protein Kinases/metabolism ; Disease Models, Animal ; Female ; Humans ; Imidazoles/pharmacology ; Life Cycle Stages/drug effects ; Malaria/drug therapy ; Mice, Inbred BALB C ; Models, Molecular ; Plasmodium chabaudi/drug effects ; Plasmodium falciparum/drug effects ; Plasmodium falciparum/growth & development ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Pyridines/pharmacology ; Treatment Outcome

المؤلفون: Dissanayake AM; Department of Endocrinology and Diabetes, Middlemore Hospital, Auckland, New Zealand., Wheldon MC; Department of Biostatistics and Epidemiology, Auckland University of Technology, Middlemore Clinical Trials, Middlemore Hospital, Auckland, New Zealand., Ahmed J; Department of Renal Medicine, Middlemore Hospital, Auckland, New Zealand., Hood CJ; Department of Renal Medicine, Middlemore Hospital, Auckland, New Zealand.

المصدر: Kidney international reports [Kidney Int Rep] 2017 Mar 29; Vol. 2 (4), pp. 705-712. Date of Electronic Publication: 2017 Mar 29 (Print Publication: 2017).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101684752 Publication Model: eCollection Cited Medium: Internet ISSN: 2468-0249 (Electronic) Linking ISSN: 24680249 NLM ISO Abbreviation: Kidney Int Rep Subsets: PubMed not MEDLINE